BioRestorative Therapies, Inc. . announced that it has entered into a supply agreement with Evolutionary Biologics, a supplier of biologic-based cosmetics. Pursuant to the supply agreement, BioRestorative, using its cGMP ISO-7 certified clean room, will manufacture tissue-based biologics for Evolutionary Biologics for cosmetic and aesthetic applications.

The first-generation product, that has been formulated and manufactured, is an umbilical cord tissue extract that is highly enriched with factors that address the signs of aging. These factors include cytokines, chemokines, growth factors and exosomes, which are known to play important roles as communication mediators between cells and have been found to have certain anti-aging effects on skin. With the Company?s expanded manufacturing capabilities, BioRestorative is able to support research and development of biologics from various aspects, especially for exosome manufacturing, engineering, quality control and potential therapeutic applications.